Antiviral nanoagents: More attention and effort needed?

The recent COVID-19 outbreak has increasingly engaged researchers in the search for effective antiviral drugs as well as therapeutic treatment options. The shortcomings of existing antiviral agents such as narrow spectrum and low bioavailability, can be overcome through the use of engineered nanomat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yongjiu, Ma, Juan, Xu, Ming, Liu, Sijin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498411/
https://www.ncbi.nlm.nih.gov/pubmed/32963581
http://dx.doi.org/10.1016/j.nantod.2020.100976
Descripción
Sumario:The recent COVID-19 outbreak has increasingly engaged researchers in the search for effective antiviral drugs as well as therapeutic treatment options. The shortcomings of existing antiviral agents such as narrow spectrum and low bioavailability, can be overcome through the use of engineered nanomaterials, which, therefore, are considered as a significant next-generation therapeutic option. Thus, the development of novel antiviral nanoagents will certainly help address several future challenges and knowledge gaps.

Ejemplares similares